EGFR is a receptor of tyrosine kinase that is overexpressed in various types of cancer such, as breast, head and neck, ovarian and non-small cell lung cancer (Salomon et al., 1996; Huang and Fu, 2015). This evidence concerns the gene EGFR and non-small cell lung carcinoma.